Epidemiology of childhood overweight & obesity in India: A systematic review

Harish Ranjani, T S Mehreen, Rajendra Pradeepa

  • 1Madras Diabetes Research Foundation & Dr Mohan's Diabetes Specialities Centre, WHO Collaborating Centre for Non Communicable Diseases Prevention & Control, IDF Centre for Education, Chennai, India.

Insights

Childhood obesity rates in India are rising, affecting both higher and lower socioeconomic groups. This trend highlights a growing public health concern for non-communicable diseases in adulthood.

Area of Science:

  • Public Health
  • Epidemiology
  • Pediatrics

Background:

  • Childhood obesity is a significant risk factor for adult non-communicable diseases (NCDs).
  • Nationwide data on childhood overweight and obesity prevalence in India is limited and lacks standardized definitions.
  • Understanding trends is crucial for public health interventions.

Purpose of the Study:

  • To review and analyze trends in childhood and adolescent overweight and obesity in India from 1981 to 2013.
  • To synthesize existing data due to the paucity of uniform nationwide studies.
  • To provide a clearer picture of the magnitude of the problem.

Main Methods:

  • A comprehensive literature search was conducted across scientific databases for studies published over three decades.
  • Keywords included "childhood obesity," "adolescent overweight," "prevalence," and "trends."
  • Additional data sources included cross-references and official agency websites.

Main Results:

  • Analysis included data from 52 studies across 16 Indian states.
  • The combined prevalence of childhood overweight and obesity increased significantly, reaching 19.3% after 2010, up from 16.3% in 2001-2005.
  • Obesity prevalence was found to be higher in northern compared to southern India.

Conclusions:

  • Overweight and obesity rates are increasing among Indian children and adolescents.
  • The rise is observed across socioeconomic strata, including lower-income groups.
  • This trend poses a growing challenge, especially as underweight remains a concern in some populations.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.5K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.3K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
334
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
274
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
363